GeoVax Price to Book Value from 2010 to 2024
GOVX Stock | USD 1.54 0.01 0.65% |
Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax main balance sheet or income statement drivers, such as Depreciation And Amortization of 70.5 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 144, Dividend Yield of 0.0 or PTB Ratio of 1.62. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
GeoVax | Price to Book Value |
About GeoVax Labs Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include GeoVax Labs income statement, its balance sheet, and the statement of cash flows. GeoVax Labs investors use historical funamental indicators, such as GeoVax Labs's Price to Book Value, to determine how well the company is positioned to perform in the future. Although GeoVax Labs investors may use each financial statement separately, they are all related. The changes in GeoVax Labs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GeoVax Labs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on GeoVax Labs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of GeoVax Labs Correlation against competitors. For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for GeoVax Stock analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is GeoVax Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GeoVax Labs. If investors know GeoVax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GeoVax Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.29) | Quarterly Revenue Growth (1.00) | Return On Assets (0.82) | Return On Equity (1.60) |
The market value of GeoVax Labs is measured differently than its book value, which is the value of GeoVax that is recorded on the company's balance sheet. Investors also form their own opinion of GeoVax Labs' value that differs from its market value or its book value, called intrinsic value, which is GeoVax Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GeoVax Labs' market value can be influenced by many factors that don't directly affect GeoVax Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GeoVax Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeoVax Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeoVax Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.